Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IBM vs MRNA✓SelectedUSD · MRNAIBM vs MRNA performance historyLatest closeAs of-1.11%11/18
Stock and ETF performance explorer

IBM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+4.0%
MRNA return
+293.7%
Excess return
-289.7%
Maximum drawdown
-37.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.1%-4.8%+3.7%-1.0%
7D-7.9%-20.9%+12.9%-7.7%
30D-2.7%-13.3%+10.6%-2.5%
3M-1.1%+212.6%-213.7%-2.8%
6M+4.0%+309.0%-305.0%+10.1%
All+4.0%+293.7%-289.7%+10.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling